<div>
  <ul>
    <li>
      <p>
        General telemedicine and telepsychiatry platform Antidote Health has raised USD 22 million in a Series A funding round. The round was co-led by third-time investor Flint Capital, iAngels, and Group 11. This brings the total raised by the company to USD 35 million.&nbsp;
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        The company will use these funds to bolster its market presence, expand its range of services across the US, and develop new products through R&amp;D. The company is specifically looking into developing new services, which would integrate AI screening and clinical decision support system capabilities.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.finsmes.com/2022/03/antidote-health-raises-22m-in-series-a-funding.html">
      FinSMEs
    </a>
  </p>
  <p>
    <a href="https://www.prnewswire.com/news-releases/antidote-health-raises-22-million-in-series-a-funding-301507235.html">
      PR Newswire
    </a>
  </p>
</div>


Mental Health Tech

Antidote Health raises USD 22 million in Series A funding

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

All Updates

Antidote Health raises USD 22 million in Series A funding

Antidote Health raises USD 22 million in Series A funding